| Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II–III esophageal carcinoma K Kato, T Eguchi Nakajima, Y Ito, C Katada, H Ishiyama, S Tokunaga, ... Japanese journal of clinical oncology 43 (6), 608-615, 2013 | 106 | 2013 |
| Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell … H Ishiyama, BS Teh, H Ren, S Chiang, A Tann, AI Blanco, AC Paulino, ... Clinical genitourinary cancer 10 (3), 196-198, 2012 | 85 | 2012 |
| MicroRNA-221 and-222 regulate radiation sensitivity by targeting the PTEN pathway C Zhang, C Kang, P Wang, Y Cao, Z Lv, S Yu, G Wang, A Zhang, Z Jia, ... International Journal of Radiation Oncology* Biology* Physics 80 (1), 240-248, 2011 | 82 | 2011 |
| Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2) K Higuchi, S Komori, S Tanabe, C Katada, M Azuma, H Ishiyama, ... International Journal of Radiation Oncology* Biology* Physics 89 (4), 872-879, 2014 | 81 | 2014 |
| Results of a questionnaire survey for symptom of late complications caused by radiotherapy in breast conserving therapy H Ishiyama, K Niino, T Hosoya, K Hayakawa Breast Cancer 13 (2), 197-201, 2006 | 62 | 2006 |
| Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy?: a systematic review H Ishiyama, T Hirayama, P Jhaveri, T Satoh, AC Paulino, B Xu, EB Butler, ... American journal of clinical oncology 37 (3), 297-304, 2014 | 57 | 2014 |
| The kinetochore protein Bub1 participates in the DNA damage response C Yang, H Wang, Y Xu, KL Brinkman, H Ishiyama, STC Wong, B Xu DNA repair 11 (2), 185-191, 2012 | 56 | 2012 |
| Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study S Namiki, T Satoh, S Baba, H Ishiyama, K Hayakawa, S Saito, Y Arai Urology 68 (6), 1230-1236, 2006 | 53 | 2006 |
| Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: an analysis to … H Ishiyama, M Kitano, T Satoh, S Kotani, M Uemae, K Matsumoto, ... International Journal of Radiation Oncology* Biology* Physics 75 (1), 23-28, 2009 | 52 | 2009 |
| Single infusion of zoledronic acid to prevent androgen deprivation therapy‐induced bone loss in men with hormone‐naive prostate carcinoma T Satoh, M Kimura, K Matsumoto, K Tabata, H Okusa, H Bessho, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 52 | 2009 |
| A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology … K Higuchi, W Koizumi, S Tanabe, T Sasaki, C Katada, H Ishiyama, ... Radiotherapy and Oncology 87 (3), 398-404, 2008 | 47 | 2008 |
| Comparison of Prophylactic Naftopidil, Tamsulosin, and Silodosin for 125I Brachytherapy–Induced Lower Urinary Tract Symptoms in Patients With Prostate Cancer: Randomized … H Tsumura, T Satoh, H Ishiyama, K Tabata, S Kotani, S Minamida, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), e385-e392, 2011 | 44 | 2011 |
| The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo Y Gao, H Ishiyama, M Sun, KL Brinkman, X Wang, J Zhu, W Mai, Y Huang, ... Radiation oncology 6, 1-8, 2011 | 41 | 2011 |
| Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer M Nakayama, K Hayakawa, M Okamoto, Y Niibe, H Ishiyama, S Kotani Japanese journal of clinical oncology 40 (10), 921-926, 2010 | 41 | 2010 |
| Prostate‐specific antigen ‘bounce’ after permanent 125I‐implant brachytherapy in Japanese men: a multi‐institutional pooled analysis T Satoh, H Ishiyama, K Matsumoto, H Tsumura, M Kitano, K Hayakawa, ... BJU international 103 (8), 1064-1068, 2009 | 40 | 2009 |
| Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy H Tsumura, T Satoh, H Ishiyama, S Hirano, K Tabata, S Kurosaka, ... World journal of radiology 7 (12), 494, 2015 | 37 | 2015 |
| Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate … H Ishiyama, N Kamitani, H Kawamura, S Kato, M Aoki, S Kariya, ... Brachytherapy 16 (3), 503-510, 2017 | 36 | 2017 |
| Stereotactic body radiation therapy for patients with pulmonary interstitial change: high incidence of fatal radiation pneumonitis in a retrospective multi-institutional study H Onishi, H Yamashita, Y Shioyama, Y Matsumoto, K Takayama, ... Cancers 10 (8), 257, 2018 | 34 | 2018 |
| Automated source tracking with a pinhole imaging system during high-dose-rate brachytherapy treatment Y Watanabe, H Muraishi, H Takei, H Hara, T Terazaki, N Shuto, T Shimo, ... Physics in Medicine & Biology 63 (14), 145002, 2018 | 33 | 2018 |
| Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy M Kubo, T Satoh, H Ishiyama, KI Tabata, H Tsumura, S Komori, ... Oncology reports 39 (1), 417-424, 2018 | 33 | 2018 |
